Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice

BackgroundBreast cancer is the first cause of cancer death among women and its incidence doubled in the last two decades. Several approaches for the treatment of these cancers have been developed. The axillary lymph node dissection (ALND) leads to numerous morbidity complications and is now advantageously replaced by the dissection and the biopsy of the sentinel lymph node. Although this approach has strong advantages, it has its own limitations which are manipulation of radioactive products and possible anaphylactic reactions to the dye. As recently proposed, these limitations could in principle be by-passed if semiconductor nanoparticles (quantum dots or QDs) were used as fluorescent contrast agents for the in vivo imaging of SLN. QDs are fluorescent nanoparticles with unique optical properties like strong resistance to photobleaching, size dependent emission wavelength, large molar extinction coefficient, and good quantum yield.MethodsCdSe/ZnS core/shell QDs emitting around 655 nm were used in our studies. 20 μL of 1 μM (20 pmol) QDs solution were injected subcutaneously in the anterior paw of healthy nude mice and the axillary lymph node (ALN) was identified visually after injection of a blue dye. In vivo fluorescence spectroscopy was performed on ALN before the mice were sacrificed at 5, 15, 30, 60 min and 24 h after QDs injection. ALN and all other organs were removed, cryosectioned and observed in fluorescence microscopy. The organs were then chemically made soluble to extract QDs. Plasmatic, urinary and fecal fluorescence levels were measured.ResultsQDs were detected in ALN as soon as 5 min and up to 24 h after the injection. The maximum amount of QDs in the ALN was detected 60 min after the injection and corresponds to 2.42% of the injected dose. Most of the injected QDs remained at the injection site. No QDs were detected in other tissues, plasma, urine and feces.ConclusionEffective and rapid (few minutes) detection of sentinel lymph node using fluorescent imaging of quantum dots was demonstrated. This work was done using very low doses of injected QDs and the detection was done using a minimally invasive method.

[1]  Heyou Han,et al.  Study on the interaction between CdSe quantum dots and hemoglobin. , 2008, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[2]  Y. Yu,et al.  Synthesis of functionalized CdTe/CdS QDs for spectrofluorimetric detection of BSA. , 2007, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[3]  R. Uren Lymphatic drainage of the skin , 2004, Annals of Surgical Oncology.

[4]  S. Davis,et al.  Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics , 1995 .

[5]  Sanjiv S Gambhir,et al.  Quantum dot imaging for embryonic stem cells , 2007, BMC biotechnology.

[6]  T. Mihaljevic,et al.  Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping , 2004, Nature Biotechnology.

[7]  Hans C. Fischer,et al.  Pharmacokinetics of Nanoscale Quantum Dots: In Vivo Distribution, Sequestration, and Clearance in the Rat , 2006 .

[8]  Sebastian Daum,et al.  On the benefit of bivalency in peptide ligand/pin1 interactions. , 2007, Journal of molecular biology.

[9]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[10]  James A J Fitzpatrick,et al.  Sentinel lymph node imaging using quantum dots in mouse tumor models. , 2007, Bioconjugate chemistry.

[11]  Steffen Hackbarth,et al.  Long-term exposure to CdTe quantum dots causes functional impairments in live cells. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[12]  L. Cohn,et al.  Sentinel lymph node mapping of the pleural space. , 2005, Chest.

[13]  L. Tafra,et al.  Comparison of intradermal and subcutaneous injections in lymphatic mapping. , 2001, The Journal of surgical research.

[14]  L. Cohn,et al.  Sentinel Lymph Node Mapping of the Gastrointestinal Tract by Using Invisible Light , 2006, Annals of Surgical Oncology.

[15]  D. Reintgen,et al.  Current status of sentinel lymph node mapping and biopsy: facts and controversies. , 2003, The oncologist.

[16]  Wen-Hsiung Chan,et al.  CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals. , 2006, Toxicology letters.

[17]  Nigel J Walker,et al.  Migration of intradermally injected quantum dots to sentinel organs in mice. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[19]  F. Guillemin,et al.  Results of Preoperative Lymphoscintigraphy for Breast Cancer Are Predictive of Identification of Axillary Sentinel Lymph Nodes , 2005, World Journal of Surgery.

[20]  C. Giardina,et al.  A Further Validation of Subareolar Injection Technique for Breast Sentinel Lymph Node Biopsy , 2006, Annals of Surgical Oncology.

[21]  John V Frangioni,et al.  Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. , 2005, The Annals of thoracic surgery.

[22]  J. Zager,et al.  Lymphatic mapping and sentinel node biopsy: a surgical perspective. , 2005, Seminars in nuclear medicine.

[23]  J. Frangioni In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[24]  Hak Soo Choi,et al.  Image-Guided Oncologic Surgery Using Invisible Light: Completed Pre-Clinical Development for Sentinel Lymph Node Mapping , 2006, Annals of Surgical Oncology.

[25]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[26]  Kazuhiko Sato Current technical overviews of sentinel lymph node biopsy for breast cancer , 2007, Breast cancer.

[27]  M. Bawendi,et al.  Sentinel lymph node mapping with type-II quantum dots. , 2007, Methods in molecular biology.

[28]  L. Cohn,et al.  Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. , 2005, The Journal of thoracic and cardiovascular surgery.

[29]  Sheryl G. A. Gabram,et al.  Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial , 2006, Annals of Surgical Oncology.

[30]  Vincent Noireaux,et al.  In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.

[31]  G. Hédelin,et al.  Cancer incidence and mortality in France over the period 1978-2000. , 2003, Revue d'epidemiologie et de sante publique.